Apolipoprotein E (apoE) has been confirmed as a risk factor for late-onset Alzheimer's disease (AD) and is associated with neurofibrillary tangles and senile plaques, the microscopic pathological characteristics of AD. There has been no direct evidence that human central nervous system neurons can take up and internalize exogenous apoE, which may be important in order for apoE to be involved in the development of the disease. This paper demonstrates by immunohistochemistry and confocal microscopy that cultured human brain neurons can take up and internalize exogenous recombinant human apoE3. We confirm that neurons express the low-density lipoprotein receptor-related protein (LRP) but do not express the low-density lipoprotein receptor. We also demonstrate that the LRP mediates the neuronal uptake of apoE.
INTRODUCTION
Apolipoprotein E (apoE denotes the protein; APOE denotes the gene) has been confirmed as a risk factor for late-onset Alzheimer's disease (AD) (Saunders et al., 1993a,b; Strittmatter et al., 1993) . ApoE has three major isoforms, each differing by a single amino acid substitution: apoE2 (cys112, cys158), apoE3 (cys112, arg158), and apoE4 (arg112, arg158). Inheritance of an APOE4 genotype increases the risk of disease and lowers the age of onset (Corder et al., 1993) . In contrast APOE2 may be protective against late-onset AD as it lowers risk and increases age of onset (Corder et al., 1994) . Immunostaining of AD brain has demonstrated that apoE is localized to neurofibrillary tangles and senile plaques (Namba et al., 1991) , the pathological characteristics of the disease. However, these pathological signs represent the end stages of a progressive disease. Despite the relationship between APOE genotype and the risk of developing late-onset AD, the role of apoE in the development of the disease and the formation of neurofibrillary tangles and senile plaques is unknown.
ApoE has long been known to be involved in lipid metabolism and is found in the vascular system, peripheral nervous system (PNS), and central nervous system (CNS). In the vascular system, apoE participates in cholesterol homeostasis by mediating the cellular uptake of lipoproteins (Weisgraber et al., 1994) . Such uptake is facilitated by the low-density lipoprotein receptor (LDLR) and the low-density lipoprotein receptor-related protein (LRP) (Mahley, 1988; Kowal et al., 1990) . In the PNS, apoE is produced and secreted by Schwann cells (Boyles et al., 1985) with synthesis increasing markedly following nerve injury (Boyles et al., 1989) . ApoE accumulates at the site of injury at high concentrations and is proposed to be a factor in the repair, growth, and maintenance of axonal membranes (Ignatius et al., 1986; Pitas et al., 1987; Mahley, 1988; Boyles et al., 1989) . In the CNS, a heavily sialylated form of apoE is synthesized principally by astrocytes
